Eurofins Scientific, the French biotech company, has made an impressive debut on Germany's Neuer Markt, as investors push hard for a revival in the high-growth market's fortunes.

Eurofins Scientific, which is already listed in France but boasts a strong presence in Germany, was met well by investors as it launched its secondary listing on Frankfurt's high-growth market. Shares in the company began trading at €39 ($32.62), up from the issue price of €35.